- Home
- Publications
- Publication Search
- Publication Details
Title
Safinamide for the treatment of Parkinson's disease
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 23, Issue 5, Pages 729-742
Publisher
Informa Healthcare
Online
2014-03-21
DOI
10.1517/13543784.2014.897694
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Non-dopaminergic Treatments for Motor Control in Parkinson’s Disease
- (2013) Susan H. Fox DRUGS
- The pharmacokinetic evaluation of selegiline ODT for the treatment of Parkinson's disease
- (2013) Tamás Tábi et al. Expert Opinion on Drug Metabolism & Toxicology
- Continuous dopaminergic delivery to minimize motor complications in Parkinson’s disease
- (2013) Brenton A Wright et al. Expert Review of Neurotherapeutics
- Current status of safinamide for the drug portfolio of Parkinson’s disease therapy
- (2013) Thomas Müller Expert Review of Neurotherapeutics
- Safinamide reduces dyskinesias and prolongs l-DOPA antiparkinsonian effect in parkinsonian monkeys
- (2013) Laurent Grégoire et al. PARKINSONISM & RELATED DISORDERS
- Rasagiline in Parkinson's disease: A review based on meta-analysis of clinical data
- (2013) Sara Mínguez-Mínguez et al. PHARMACOLOGICAL RESEARCH
- Disposition and Metabolism of Safinamide, a Novel Drug for Parkinson's Disease, in Healthy Male Volunteers
- (2013) Chiara Leuratti et al. PHARMACOLOGY
- Tremorolytic effects of safinamide in animal models of drug-induced parkinsonian tremor
- (2013) Samantha Podurgiel et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Effects of ketoconazole treatment on the pharmacokinetics of safinamide and its plasma metabolites in healthy adult subjects
- (2012) Sonja Krösser et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease
- (2012) A. H. V. Schapira et al. EUROPEAN JOURNAL OF NEUROLOGY
- Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson’s disease
- (2012) Dénes Zádori et al. JOURNAL OF NEURAL TRANSMISSION
- Kynurenines in the CNS: recent advances and new questions
- (2012) László Vécsei et al. NATURE REVIEWS DRUG DISCOVERY
- Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism
- (2012) David N. Hauser et al. NEUROBIOLOGY OF DISEASE
- Drug therapy in patients with Parkinson’s disease
- (2012) Thomas Müller Translational Neurodegeneration
- Monoamine Oxidase B Inhibitors for the Treatment of Parkinsonʼs Disease
- (2011) Anthony H.V. Schapira CNS DRUGS
- Levodopa–carbidopa intestinal gel for treatment of advanced Parkinson’s disease
- (2011) H.H. Fernandez et al. CURRENT MEDICAL RESEARCH AND OPINION
- Kynurenines in Parkinson’s disease: therapeutic perspectives
- (2011) Dénes Zádori et al. JOURNAL OF NEURAL TRANSMISSION
- Altered tryptophan metabolism in Parkinson's disease: A possible novel therapeutic approach
- (2011) Nikoletta Szabó et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease
- (2011) Aristide Merola et al. MOVEMENT DISORDERS
- A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients
- (2011) Fabrizio Stocchi et al. MOVEMENT DISORDERS
- Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa
- (2011) Yoland Smith et al. NEUROPSYCHOPHARMACOLOGY
- Pharmacological Therapy in Parkinson's Disease: Focus on Neuroprotection
- (2010) Zsigmond Tamas Kincses et al. CNS Neuroscience & Therapeutics
- Levodopa and 3-OMD levels in Parkinson patients treated with Duodopa
- (2010) A. Antonini et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Safinamide in the treatment of Parkinson's disease
- (2010) Anthony HV Schapira EXPERT OPINION ON PHARMACOTHERAPY
- Continuous Jejunal Levodopa Infusion in Patients With Advanced Parkinson Disease
- (2009) Karla Eggert et al. CLINICAL NEUROPHARMACOLOGY
- Novel therapeutic strategies in Parkinson’s disease
- (2009) Peter Klivenyi et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies
- (2009) D. Zádori et al. JOURNAL OF NEURAL TRANSMISSION
- The role of kynurenines in disorders of the central nervous system: Possibilities for neuroprotection
- (2009) Eniko Vamos et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
- (2009) K Ray Chaudhuri et al. LANCET NEUROLOGY
- Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease
- (2009) David Devos et al. MOVEMENT DISORDERS
- The scientific and clinical basis for the treatment of Parkinson disease (2009)
- (2009) C. W. Olanow et al. NEUROLOGY
- The hypothesis of the genesis of motor complications and continuous dopaminergic stimulation in the treatment of Parkinson's disease
- (2009) Fabrizio Stocchi PARKINSONISM & RELATED DISORDERS
- Eighteen month study of continuous intraduodenal levodopa infusion in patients with advanced Parkinson's disease: Impact on control of fluctuations and quality of life
- (2009) V. Puente et al. PARKINSONISM & RELATED DISORDERS
- Enteral Levodopa/Carbidopa Infusion in Advanced Parkinson Disease
- (2008) Dag Nyholm et al. CLINICAL NEUROPHARMACOLOGY
- Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: An in vivo 11C-raclopride PET study
- (2008) Marios Politis et al. EXPERIMENTAL NEUROLOGY
- An expert opinion on safinamide in Parkinson's disease
- (2008) Marco Onofrj et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease
- (2008) Robert A. Hauser et al. MOVEMENT DISORDERS
- Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease
- (2008) Robert A. Hauser et al. MOVEMENT DISORDERS
- Selegiline reduces cisplatin-induced neuronal death in neuroblastoma cells
- (2008) Thomas Müller et al. NEUROLOGICAL RESEARCH
- Metabotropic Glutamate Receptors 5 Blockade Reverses Spatial Memory Deficits in a Mouse Model of Parkinson's Disease
- (2008) Elvira De Leonibus et al. NEUROPSYCHOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now